Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing significant correlations. Higher scores correlate with increased heart failure ...
Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...
The Enhanced Liver Fibrosis (ELF) test is a valuable tool for detecting progression to advanced fibrosis in MASLD.
New research and updated guidelines highlight the urgent need to standardize noninvasive liver fibrosis screening as metabolic dysfunction-associated steatotic liver disease (MASLD) cases climb ...
Liver steatosis is more prevalent than liver fibrosis in people with HIV, with significant risk factors including age, hypertension, and diabetes. Liver fibrosis prevalence is low, with integrase ...
In addition to the DTA Fibrosis Score, VIDA’s ILD offering enables the following trial services: • Enhanced eligibility assessments, supported by novel, patented visualizations, including Tomographic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results